AG0034KJ

59-14-3 | 5-Bromo-2'-deoxyuridine

AG0034KJ

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	59-14-3
Catalog Number	AG0034KJ(AGN-PC-0OCUMB)
Chemical Name	5-Bromo-2'-deoxyuridine
EC Number	200-415-9
IUPAC Name	5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI	InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
InChI Key	WOVKYSAHUYNSMH-RRKCRQDMSA-N
MDL Number	MFCD00006529
Molecular Formula	C9H11BrN2O5
Molecular Weight	307.0980
RTECS Number	YU7350000
SMILES	BrC=1C(NC(N([C@H]2C[C@H](O)[C@@H](CO)O2)C1)=O)=O
UNII	G34N38R2N1
Synonyms	5 Bromo 2' deoxyuridine, 5 Bromodeoxyuridine, 5-Bromo-2'-deoxyuridine, 5-Bromodeoxyuridine, BrdU, Bromodeoxyuridine, Bromouracil Deoxyriboside, Broxuridine, BUdR, Deoxyriboside, Bromouracil, NSC-38297, 5-BROMO-2'-DEOXYURIDINE, 59-14-3, Broxuridine, 5-Bromodeoxyuridine, 5-BrdU, BRDU, Bromodeoxyuridine, BUDR, 5-Bromouracil deoxyriboside, Bromouracil deoxyriboside, 5-Bromodesoxyuridine, 5-Bdu, Broxuridinum, Broxuridina, 5-Bromouracil-2-deoxyriboside, 5-Bromo-2-deoxyuridine, bromodeoxyuridine (brdu), Broxuridinum [INN-Latin], Broxuridina [INN-Spanish], Uridine, 5-bromo-2'-deoxy-, C9H11BrN2O5, Bromoouridine, MFCD00006529, NSC-38297, Radibud, CCRIS 818, Brudr, UNII-G34N38R2N1, HSDB 7477, CHEBI:472552, EINECS 200-415-9, 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil, 5-Budr, 5-bromo-2'-deoxy uridine, BRN 0030395, CHEMBL222280, G34N38R2N1, 5-Bromo-2'-deoxyuridine (BRDU), NCGC00090770-05, NSC 38297, 5-bromo-2'-desoxyuridine, DSSTox_CID_13105, DSSTox_RID_79051, DSSTox_GSID_33105, brdurd, 5-Bromo-2'-deoxyuridine, 99+%, BDU, 5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione, 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione, CAS-59-14-3, 1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-1,3-dihydropyrim idine-2,4-dione, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, SMR001227189, Broxuridine [INN], Broxuridine [INN:JAN], AK-44014, 5-Bromo-dURD, bromodeoxyuridine-brdu, AC1L1LNR, Broxuridine (JAN/INN), Maybridge4_003385, Epitope ID:138105, AC1Q24DG, cid_6035, Lopac0_000212, SCHEMBL27755, 4-24-00-01234 (Beilstein Handbook Reference), KSC911S7T, MLS001055406, MLS002153366, DTXSID7033105, CTK8B1979, 5-Bromo-2'-deoxyuridine(BRDU), 5-Bromo-2'-deoxyuridine, 97%, WOVKYSAHUYNSMH-RRKCRQDMSA-N, ZX-AFC000364, HMS1619B05, HMS3039G15, HMS3260L05, BCP21681, KS-00000JJ3, ZINC1081243, 5-BROMO-2''-DEOXY URIDINE, Tox21_111016, Tox21_200106, Tox21_500212, ANW-33171, BDBM50207303, BI2048, CB-072, HG1160, LS-250, SBB002964, STL530083, AKOS001715166, AKOS016015753, Tox21_111016_1, CCG-204307, CS-3028, DB12028, LP00212, MCULE-5086148258, uridine, 3-15N-5-bromo-2'-deoxy-, NCGC00090770-01, NCGC00090770-02, NCGC00090770-03, NCGC00090770-04, NCGC00090770-06, NCGC00090770-07, NCGC00090770-08, NCGC00090770-09, NCGC00175901-01, NCGC00257660-01, NCGC00260897-01, AJ-24922, AN-15303, AS-11762, BR-44014, CC-21273, HY-15910, SC-18439, ST057095, AB0010697, AX8021654, DB-053327, 5-Bromo-2'-deoxyuridine, >=99% (HPLC), EU-0100212, 5-Bromo-2'-deoxyuridine, BioUltra, >=99%, 5-Bromo-1-(2-deoxy-|A-D-ribofuranosyl)uracil, 5-Bromo-2'-deoxyuridine, >=99.0% (HPLC), B 5002, D01763, S-2807, 5- Br-2 inverted exclamation mark -deoxyuridine, 006B529, 140455-EP2277565A2, 140455-EP2277566A2, 140455-EP2277567A1, 140455-EP2277568A2, 140455-EP2277569A2, 140455-EP2277570A2, 140455-EP2292280A1, 156905-EP2284178A2, 156905-EP2284179A2, 5-Bromo-2 inverted exclamation marka-deoxyuridine, C-30689, SR-01000075718, J-700086, SR-01000075718-1, Br-dU; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil, Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone, 5-bromo-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-4-hydroxypyrimidin-2(1H)-one, 396726-49-1, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyridine-2,4(1H,3H)-dione, 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione, broxuridin-, 5 Bromodeoxyuridine, 5 Bromo 2' deoxyuridine, Deoxyriboside, Bromouracil, D0M4MA, Uridina, 5-bromo-2'-desoxi-, C9-H11-Br-N2-O5, CID6035, DRG-0309, AR-1I0744, 5-Bromo-2'-deoxyuridine (broxuridine), 5-Bromo-2'-deoxyuridine, 99% - 1G 1g, B1575, A13369, D001973, 7511-39-9, DBU,

Complexity	386
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	3
Defined Bond Stereocenter Count	0
Exact Mass	305.985g/mol
Formal Charge	0
Heavy Atom Count	17
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	307.1g/mol
Monoisotopic Mass	305.985g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	99.1A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-0.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number